Living with Diabetes? Check out our site for you

Healthcare professional? This is your dedicated site.

You are here

Home » Products » MiniMed 780G

MiniMedTM 780G insulin pump system ^

Anticipates
Adjusts.
Corrects.*1-4

Automated to help more patients reach glycaemic targets with less effort1-4

^ Components sold separately

Always Read the Instruction for Use. Medtronic's (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with type one diabetes. Guardian™ Sensor 3 may also be used as part of the MiniMed® 780G system^ for people living with Type 1 diabetes age 7 and up.

*Compared to the MiniMedTM 670G system. Refers to SmartGuardTM feature. Some user interaction required.

Individual results may vary.

MM780G Devices

See for yourself

Open MiniMed 780G™ Virtual Demo

See for yourself

Everyday challenges.1-4
for your patients.

Insulin needs vary 24/7

Everyday challenges chart

42

factors may affect blood glucose levels.5

CARB COUNTING

Patients aren't perfect

50%

1 out of 3 high glucose episodes aren't followed by a correction bolus6

50%

1 out of 2correction boluses are incorrectly calculated for managing hyperglycemia.7

 

Carb counting sucks

50%

Nearly 50% of people with T1D consider counting carbohydrates as the most burdensome aspect of diabetes self-care.5

50%

59% of people with T1D do not count meal carbohydrates correctly.6

Adjusts and corrects,
every 5 minutes, as needed* through automatic insulin delivery.

SmartguardTM Technology

Everyday challenges chart

A

Selection between a basal target of 5.5 mmol/L (default setting), 6.1 mmol/L or 6.7 mmol/L

B

The auto correction target is set at 6.7 mmol/L

C

Basal insulin adjusts every 5 minutes based on sensor glucose (SG) values

D

Auto corrections delivered as needed, as frequently as every 5 minutes

Engineered for living

 
Stop watch

SmartguardTM Auto Bolus:

Bolus is delivered automatically up to every 5 minutes if algorithm determines it's needed:

  • Maximum auto basal delivery is reached
  • SG is above 6.7mmol/L
  • Helps adjusts for inaccurate carb count1
 

Apple and Android mobile apps.

Mobile

Patients track time in range. Set alerts.†

MiniMedTM Mobile App

Mobile

Share real time with care partners.†

CarelinkTM Connect App

Kids playing football

Automatic CareLink uploads†

Laptop, desktop and tablet

CareLinkTM Software

Insights support meaningful conversations with your patients.

Access to data

Automatic and secure uploads of patient data.† CareLinkTM reports update every 24 hours.

Virtual Visits

Patients can share data without leaving home.

MiniMedTM 780G insulin pump system ^

More time in range. *1,3,4,10

Everyday challenges chart

On target with less effort*1-4

84% of subjects achieved GMI goal with optimised settings versus 52% at baseline.

GMI GraphGraph Legend

79% of subjects achieved Time in Range goal after study period with optimised settings versus 45% at baseline.

Time in Range Graph

You and our algorithm

1

Re-calculates EVERY midnight

The ONLY available algorithm that re-calculates Total Daily Dose and Insulin Sensitivity Factor based on actual insulin delivered every 24 hours.

2

Treat to target not a range

The ONLY algorithm that has choice of targets (5.5mmol/L, 6.1mmol/L or 6.7mmol/L).

3

No basal rates in Smartguard feature

The ONLY algorithm where insulin delivery is calculated EVERY 5 minutes based on actual Sensor Readings.

Algorithm Table

Evolving freedom

     
MiniMedTM 640G System MiniMedTM 670G/770G System MiniMedTM 780G System^
    ✓ Automatically corrects highs when they occur
    ✓  Personalised diabetes goals Glucose target choice to (5.5,6.1,6.7 mmol/L)
   770G Only ✓ Smartphone applications:
Patient app
Care partners app
   770G Only ✓ Future-ready software updates and upgrades (subject to availbility per local regulations)
  ✓ ✓ Automatically adjust insulin delivery
✓ ✓ ✓ Predicts lows and suspends insulin to help prevent lows1-4
✓ ✓ ✓ Susepends insulin at a preset low level

REFERENCES 1. Carlson, AL. et al. Poster at the 80th International Conference of the American Diabetes Association, June 12-16. 2020, Chicago/Virtual. 2. Medtronic data of file. Pivotal Trial (Age 14-78). N=157. 2020; 16 US sites. 3. Battelino T, et al. Diabetes Care 2019; 42(8): 1593-1603. 4. ADA Guidelines https://www.diabetes.ord/a1c. 5.Brown A. Diatribe.org. https://diatribe.org/42factors Accessed June 4, 2020. 6. Westen SC. et al. Journal of Pediatric Psychology, 44(1), 2019, 21–31. 7. Glaser NS, et al. JPEM. 2004:17(12):1641-1651. 8 Medtronic data on file. 25-minute survey, N=498 T1D individual in Germany, Japan, US, Brazil, August 2019. 9. Meade LT et al. Clin Diabetes. 2016;34(3). 10. Collyns .O. et al. Poster at the 80th International Conference of the American Diabetes Association, June 12-16. 2020, Chicago/Virtual.

*Refer to System User Guide – SmartGuard™ feature. Some user interaction required. †Patient must use MiniMed™ Mobile app with Sync to CareLink™ feature turned on. ‡Refer to CareLink™ Connect app Instructions for Use. CareLink™ Connect app requires internet connection.